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MODIFICATION OF ULTRAVIOLET CARCINOGENESIS BY PHOTOACTIVE
AGENTS*
PRELIMINARY REPORT
FREDERICK URBACH, M.D.
That prolonged exposure to ultraviolet light
can produce cancer of the skin and of other ex-
posed organs (eye, mucosa, etc.) has long been
suspected in humans (1) and has been experi-
mentally proven in animals (2—7). The details
of absorption of ultraviolet energy of various
wavelengths by the skin have been well re-
viewed by Ellis and Wells (8), and the voluminous
literature concerning ultraviolet carcinogenesis
brought up to date by Blum (9, 10). No attempt
will be made in this communication to discuss
the many and varied studies concerned with
this problem which have been carried out since
Findlay (2) demonstrated that cutaneous cancer
could be produced in the skin of mice by repeated
exposure to mercury arc radiation.
The development of a pure chemical compound,
methoxsalen, capable of producing extreme
photosensitivity in the skin of humans and
animals, has reawakened interest in the relation-
ship of photoactive agents to ultraviolet carcino-
genesis. The experiments to be reported here are
in part a repetition, and in part an extension of
the work of O'Ncal and Griffin (11) who noted
that methoxsalen given intraperitoncally po-
tentiated, while the psoralen given orally pro-
tected against ultraviolet induced skin cancer in
albino mice.
METHOD
Groups of randomly selected female ICR Swiss
mice, obtained from the Roswell Park Memorial
Institute breeding colony at six weeks of age, were
exposed to whole body radiation from Westing-
house fluorescent sunlamps five days weekly for
a period of 175 days. The ultraviolet source con-
sisted of four FS4OT12 Westinghouse lamps, ar-
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ranged in parallel in a specially designed polished
aluminum reflectort. The mice were kept in a wire
basket cage constructed so as to prevent huddling
or movement, placed 42 cm. below the fluorescent
fixture. The entire unit was built into a standard
laboratory fume hood with a glass sliding door,
partly to protect the laboratory personnel, partly
to allow for evacuation of ionized air. (Fig. 1)
The output of the fluorescent "sun" lamps was
measured continuously during each treatment
with a Westinghouse Rentschler "click" meter
(Model SM200) equipped with a WL767 photo-
tube and precalibrated against a standard lamp
tested by the United States Bureau of Standards.
Each click of the meter represented 13.69 X 10
ergs/cm2, and each group of animals received 25
click units (34.225 X 1O ergs/cm2) daily. The
relative energy distribution of the ultraviolet
source used is shown in Figure 2. As can be seen,
the lamps emit a continuous spectrum from 2750
to 3600 A.
Except during the ultraviolet exposures, all
mice were kept in plastic cages, eight animals to
the box, and given ground purina chow and water
ad libitum. All animals were housed in the same
room under identical conditions of light and tem-
perature.
The animals were weighed, sexed and randomly
divided into groups of 24 each, and then pretreated
as follows:
Group I—Topical Administration
Ta. Methoxsalen—0.1% in absolute ethanol
Tb. Crude coal tar—3.0% in chloroform
Ic. Atabrine—0.1% in absolute alcohol
Id. Hematoporphyrin—0.1% in absolute alco-
hol
le. Control—untreated
Group 11—0 rot Administration
ha. Methoxsalen—0.5 gm/kg diet
JIb. Atabrine—50 mg/kg diet
t We are indebted to Dr. Rudolph Nagy, Ad-
visory Engineer of the Research Department of
the Lamp Division of Westinghouse Electric Cor-
poration for designing this unit, and for much
invaluable information and many helpful sugges-
tions. The Atlantic Ultraviolet Company built the
ultraviolet unit.
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FIG. 1. Ultraviolet unit (a) hood (b) ultraviolet fluorescent lamps in reflectors (c) wiremesh cage (d)
phototube in housing. Distance from lamps to animals, 42 cm.
FIG. 2. Relative energy distribution of Westinghouse fluorescent sun lamps.
Group III—Parenteral
lila. Methoxsalen—O.4 mg. intraperitoneally,
daily 1 hour pre-treatment
11Th. Hematoporphyrin—2.5 mg. intraperi-
toneally daily 1 hour pre-treatment
Tile. Control—Acacia intraperitoneally daily
1 hour pre-treatlnent
Each group of animals was exposed to ultra-
violet simultaneously in a single wire cage, 5
days each week. The length of exposure was the
amount of time needed to deliver 25 "click" units
as measured by the photo tube placed during each
experiment at the level of the wire mesh mouse
cage. (Fig. 1)
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The topical preparations were freshly prepared
every two weeks, and applied to the top of each
ear with one stroke of a camels hair brush. Me-
thoxsalen was obtained in pure form from P. B.
Elder Company, atabrine powder from Winthrop
Laboratories, hematoporphyrin from Mann
Laboratories, and tar from the Stock Crude Coal
Tar (McKesson & Robbins Co.) carried by the
Institute pharmacy.
For oral administration, exactly weighed out
quantities of methoxsalen and of atabrine were
dissolved and then mixed with pulverized purina
chow in a standard laboratory food grinder. For
intraperitoneal injection, the psoralen was sus-
pended in a diluent consisting of 10% ethanol,
5% glycerin, 1% pectin and water q.s. The he-
matoporphyrin (HP) solution was prepared as
follows: 2 gm. HP were weighed, dissolved in 80
ml. of 1% aqueous NaOH, and 50 ml. sterile iso-
tonic saline added. The pH was then adjusted to
7.4 by slow addition of 0.2 normal HCI, the solu-
tion quantitatively transferred to a 200 ml.
volumetric flask and the final volume made up to
200 ml. by addition of isotonic saline. The solu-
tion was filtered through a Selas filter (0.03 pore
size), transferred to sterile serum bottles, capped
and stored at 4°C. The dose (2.5 mg. per 20 gm.
mouse) was arrived at on basis of unpublished
toxicity experiments carried out by a member of
the Institute staff (12).
The mice were weighed and examined at two
to three week intervals for degree of searing and
erythema of ears, nose and tail, and for tumor
formation. Histologic study of the tumors is being
carried out, and will be reported at a later date.
All groups received ultraviolet irradiation for
a total of 175 days, for a total dose of 5.99 X 10
ergs/cm2 of mid ultraviolet (2800—3600 A) energy.
RESULTS
The results of the experiments reported here
are preliminary only, and are compiled for pre-
TIME IN WEEKS
FIG. 3. Incidence of ear tumors in Swiss mice treated with methoxsalen (8MP) administered locally,
intraperitoneally and orally. The difference in the number of tumors present at the end of radiation is
statistically significant between the controls and the groups given methoxsalen locally and intraperi-
toneally, but not significant between the controls and the group given the psoralen orally.
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Fin. 4. Incidence of ear tumors in Swiss mice treated with hematoporphyrin, atabrine and crude coal
tar. Local application of atabrine causes complete protection. Local application of crude coal tar causes
highly significant increase in number of tumors. Oral administration of atabrine and local administration
of hematoporphyrin results in no significant difference from the controls.
sentation to this conference. A complete final
report will be prepared for publication at a later
date.
At the time radiation was discontinued, a total
dose of 5.99 X 108 ergs/cm2 of ultraviolet with a
wavelength of 2800—3600 A had been given,
and 20% of the control animals had developed
ear tumors. These values are in close agreement
with those published by Rush et al. (13), Griffin
(3) and O'Neal et al. (11).
Of the animals pre-treated with intraperitoneal
methoxsalen, 68% had developed tumors, and all
showed marked erythema, scarring, alopecia and
thickening of face, ears and tail. The group
painted locally with 0.1% methoxsalen on the
ears showed as severe skin changes, and an
incidence of ear tumors of 52% which rose rapidly
in the ensuing two weeks. These two groups
(Ta and lila) showed the most marked skin
changes, and a statistically significant increase
in ear tumor formation (Fig. 3).
Group ha (methoxsalen orally) showed about
as much searing and erythema as the control
groups (Ic, Ilic) and a slight increase in the
number of ear tumors, which at the time of
evaluation was statistically not significant.
Local application of HP (Group Id) and in-
gestion of atabrine (Group lib) resulted in no
deviation fron the changes observed in the
controls, nor in a significant alteration in ear
tumor incidence. Local applications of atabrine
(Group Ic) to the ears resulted in complete
protection against erythema and tumor forma-
tion (Fig. 4).
The most spectacular changes were noted in
the animals treated locally with crude coal tar
(Group Ib). Papillomas began to form about
the fourteenth week, and typical carcinomas
16 weeks after start of therapy. Even before
cessation of radiation, 100% of the animals had
either papillomas or carcinomas or both (Fig. 4).
A control group treated with locally applied
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tar alone was started later, and while it is too
early to be absolutely certain, it appears that
tar application without ultraviolet causes papil-
lomas to develop much later, and in lesser num-
ber.
The data obtained on the animals treated with
intraperitoneal HP could not be evaluated, since
the majority of the experimental mice died 14
to 18 weeks after the onset of the experiment,
apparently of chronic intoxication.
DISCUSSION
The results of these experiments confirm again
the previously quoted findings of Rush et at. (13),
Griffin (3) and O'Neal et at. (11) as to the amount
of mid-ultraviolet energy necessary to produce
skin tumors in albino mice.
There is however a marked difference between
our results, and those obtained by O'Neal et at.
(11) as far as the demonstration of a protective
effect of orally administered methoxsalen is
concerned. We have been unable to observe such
an effect. If anything, there appears to be a slight
sensitization to ultraviolet at this time. The
reason for this discrepancy is not immediately
apparent. An attempt was made to reproduce
O'Neal's experiments as closely as possible,
except for the type of ultraviolet light source.
The major differences between the mercury are
lamps used by O'Neal and the fluorescent "sun"
lamps used by us lie in their emission spectra.
Approximately 75% of the energy output of the
mercury ares lies below 2800 A and the mercury
spectrum consists of discrete lines, while our
fluorescent lamps have a continuous spectrum
entirely in the mid-ultraviolet with a marked
peak from 3000 to 3250 A (i.e., in the area of
maximum erythema production) (Fig 2). It is
known that short ultraviolet radiation is able
to destroy a variety of chemical compounds
(e.g., destruction of sterols by ultraviolet of
2537 A), and Lerner (14) has shown that pro-
longed irradiation of methoxsalen in vitro with
mercury ares changes its absorption spectrum.
It is tempting to suggest the possibility that
methoxsalen given orally may be changed during
its passage through the gut and liver into an
intermediate compound, still able to photo-
sensitize, but perhaps more easily destroyed by
the chemical effects of short ultraviolet. Such a
hypothesis could explain the marked difference
between our observations and those of O'Neal
et at. (11). Until the intermediary pathways
of methoxsalen are better defined, such an
explanation must remain highly speculative,
and subject to further experimentation. The
increase in searing and in ear tumor formation
following local psoralen application is a reasonable
corollary to its known, potent photosensitizing
capacity following external use.
The complete protection afforded by local
application of atabrine is not surprising in view
of the strong absorption of this compound in the
medium ultraviolet. The lack of protection
afforded by oral administration of atabrine
may be due to insufficient dosage. It is however
interesting in light of the observations of
Cahn et at. (15) that atabrine, given to humans
in therapeutic doses, does not affect the normal
erythema threshold, but is able to suppress
abnormal reactions to ultraviolet light.
The spectacular carcinogenic capacity of
locally applied crude coal tar combined with
ultraviolet irradiation is worth singling out. Crude
coal tar has long been suspected of being a
photosensitizer and used as such in the medical
management of certain skin diseases (e.g.,
Goeekermann treatment of psoriasis). If the
difference in number of tumors and in the rate
of their appearance that is suggested by our
preliminary control experiments holds up in the
final analysis, it might turn out that the combina-
tion of crude coal tar and ultraviolet constitutes
one of the most potent carcinogenic agents for
rodents, and may be of interest in the study of
human skin eareinogenesis as well.
Finally, these experiments seem to show, as
has been previously suggested (11), that com-
pounds which cause a marked increase in the
chemical reaction of mouse skin to ultraviolet
light also increase the careinogenicity of this
type of radiation, while those which interfere
with the burning effect decrease the rate of
ultraviolet cancer production.
SUMMARY
1. The effect of several known photoaetive
compounds (methoxsalen, HP, crude coal tar,
and atabrine) on ultraviolet skin eareinogenesis
in albino mice has been studied. These com-
pounds were administered locally, orally and
intraperitoneally in appropriate concentrations.
Mid range ultraviolet (wavelengths 2800—3600
A) was administered daily by means of a bank of
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Westinghouse fluorescent "sun" lamps to a total
dose of 5.99 X 10 ergs/em1, divided over a period
of 175 days.
2. Local aRd intraperitoneal administration
of methoxsalen resulted in a significant increase
in the number of ear tumors present at the time of
discontinuation of the radiation. Contrary to
previous reports, no evidence of any protective
effect of orally administered psoralen could
be demonstrated.
3. Local administration of atabrine com-
pletely protected the animals against the effects
of intense ultraviolet radiation, and completely
suppressed tumor formation. Oral atabrine and
local application of crude coal tar to the ears
of the animals caused rapid development of
papillomas and carcinomas. The result of in-
jected hematoporphyrin could not be evaluated
because of excessive early mortality, presumably
due to the toxic effects of the drug.
4. The findings are discussed, particularly in
respect to the possible causes for the lack of
protective effect of oral methoxsalen, which
may be due to the absence of short ultraviolet
radiation inherent in the emission spectrum
of fluorescent "sun" lamps.
ACKNOWLEDGMENTS
The author is indebted to Mr. J. E. Freeman
and Mrs. R. Simons for splendid technical
assistance. The generosity of Paul B. Elder Co.
and Winthrop Laboratories for supplying large
quantities of methoxsalen and atabrinc is grate-
fully acknowledged.
REFERENCES
1. UNNA, P. G.: Die Histopathologie der Haut-
krankheiten. A. Hirschwald, Berlin, p. 725,
1894.
2. FINDLAY, G.M.: Ultraviolet light and cancer.
Lancet, 2: 1070, 1928.
3. GEIFFIN,A.C.,DOLMAN,V.S.,BAHLKE,E.B.,
BOUvART, D. AND TATU, E. D.: The effect
of visible light on the carcinogcnicity of
ultraviolet light. Cancer Research, 15: 532,
1955.
4. PUT5CHAR, W. AND HOLTZ, F.: Erzeugung von
Hautkrebsen hei Ratteu dureh langdauernde
Ultraviolett Bestrahlung. Ztsch. f. Krebs-
forsch., 33: 219, 1930.
5. Rono, A. H.: Cancer et soleil. Carcinoma et
sarcoma provoqué par l'actioD du soleil in
toto. Bull. Assoc. Franc. étude Cancer, 23:
59, 1933.
6. HERLITZ, C. W., JUNDELL, I. AND WAHLGEEN,F.: Durch Ultraviolett Bestrahluug er-
zengte maligne Neubildungen bei Weissen
Mausen. Acta Poediat., 10: 321, 1931.
7. BAIN, J. A. AND Ruscu, H. P.: Carcinogenesis
with ultraviolet radiation of wave length
2800—3400 Angstrom. Cancer Research, 3:
435, 1943.
S. ELris, C., WELLS, A. A. AND HEGRATH, F. F.:
The Chemical Action of Ultraviolet Rays.
Reinhold Pub!. Co., N. Y., 1941.
9. BLUM, H. F.: Photodynamic Action and Dis-
eases Caused By Light. N. Y., Reinhold
PubI. Co., 1941.
10. BLUR, H. F.: Ultraviolet Radiation and Can-
cer. In: A. Hollaender (ed) Radiation Biol-
ogy, Vol. 2. N. Y. McGraw-Hill, 1955.
11. O'NEAL, M. A. AND GRIFFIN, A. C.: The effect
of oxypsnralen upon ultraviolet carcinogen-
esis in albino mice. Cancer Research, 17:
911, 1957.
12. HOFFMETSTEE, F. S. AND LAPLATNEY, D.:
Influence of Hematopnrphyrin on X-Ray
Damage to Ehrlich-Lettre Ascites Tumor.
RPMI Interdepartmental Report, 1956.
13. Ruscu, H. P., KLINE, B. E. AND BAUMANN,
C. A.: Carcinogenesis by ultraviolet rays
with reference to wave length energy. Arch.
Path., 31: 135, 1941.
14. LERNER, A. A., DENTON, C. H. AND FITZFAT-
RICK, T. B.: Clinical and experimental
studies with 8-methnxypsnralen in vi-
tiligo. J. Invest. Dermat., 20: 299, 1953.
15. CAHN, M. H., LEVY, E. J. AND SHAFFER, B.:
Polymorphous light eruption. The effect of
chloroquine phosphate in modifying reac-
tions to ultraviolet light. J. Invest. Dermat.,
26: 201, 1956.
